Opinion: The brain health paradox: Dementia rates have fallen even as drugs have failed
Billions of dollars have been spent in pursuit of a pharmaceutical treatment for Alzheimer’s and other forms of dementia. Their fail rate through the 21st century is stuck at 100%.
The dominant story promoted by Alzheimer’s advocacy organizations, pharmaceutical companies, and academic experts has been that, without a cure, aging societies will face a demographic tidal wave of dementia—a “silver tsunami” unleashing devastating socioeconomic consequences.
